Medasense Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Medasense General Information

Description

Developer of pain monitoring devices designed to quantify pain response to optimize care and avoid overmedication. The company's devices acquire, process, and analyze dozens of physiological parameters, transforming them into a single index using artificial intelligence algorithms, enabling clinicians to get insight throughout the pain management process for accurate and personalized pain care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Hachilazon Street
  • Ramat Gan 5252268
  • Israel
+972
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Other Devices and Supplies
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, TMT, HealthTech
Corporate Office
  • 4 Hachilazon Street
  • Ramat Gan 5252268
  • Israel
+972

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medasense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 26-Mar-2023 Completed Generating Revenue
8. Secondary Transaction - Private 01-Feb-2021 Completed Generating Revenue
7. Later Stage VC (Series C) 14-Aug-2020 Completed Generating Revenue
6. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
5. Later Stage VC (Series B) 23-May-2016 Completed Generating Revenue
4. Early Stage VC 01-Apr-2012 Completed Startup
3. Accelerator/Incubator 01-Jan-2011 Completed Startup
2. Accelerator/Incubator 01-Jan-2011 $2M Completed Startup
1. Seed Round 01-Jul-2008 $2M $2M Completed Startup
To view Medasense’s complete valuation and funding history, request access »

Medasense Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A
Preferred A
Preferred A
Preferred A 47,251 $0.8 $0.8 1x $0.8 1.57%
Ordinary 60,704 $32.95 $32.95 1x $32.95 2.01%
To view Medasense’s complete cap table history, request access »

Medasense Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pain monitoring devices designed to quantify pain response to optimize care and avoid overmedication. The c
Monitoring Equipment
Ramat Gan, Israel
27 As of 2024

Berlin, Germany

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medasense Competitors (5)

One of Medasense’s 5 competitors is Dolosys, a Formerly VC-backed company based in Berlin, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dolosys Formerly VC-backed Berlin, Germany
Biotricity Formerly VC-backed Redwood City, CA
KARL STORZ Corporation Tuttlingen, Germany
MDoloris Medical Systems Venture Capital-Backed Loos, France
Meril Life Sciences Private Equity-Backed Vapi, India
You’re viewing 5 of 5 competitors. Get the full list »

Medasense Patents

Medasense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220233139-A1 Device, system and method for perioperative pain management Pending 20-May-2019
EP-3972487-A1 Device, system and method for perioperative pain management Inactive 20-May-2019
EP-3972487-A4 Device, system and method for perioperative pain management Inactive 20-May-2019
US-20210315633-A1 Systems and methods for monitoring physiological parameters during diathermy Active 22-Jul-2018
EP-3823529-A4 Systems and methods for monitoring physiological parameters during diathermy Pending 22-Jul-2018 A61B5/7225
To view Medasense’s complete patent history, request access »

Medasense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medasense Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deloitte Launchpad Accelerator/Incubator
Sabadell Venture Capital Corporate Venture Capital Minority
MedTech Innovator Accelerator/Incubator
Baxter Ventures Corporate Venture Capital Minority
OTV Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Medasense FAQs

  • When was Medasense founded?

    Medasense was founded in 2008.

  • Where is Medasense headquartered?

    Medasense is headquartered in Ramat Gan, Israel.

  • What is the size of Medasense?

    Medasense has 27 total employees.

  • What industry is Medasense in?

    Medasense’s primary industry is Monitoring Equipment.

  • Is Medasense a private or public company?

    Medasense is a Private company.

  • What is Medasense’s current revenue?

    The current revenue for Medasense is .

  • How much funding has Medasense raised over time?

    Medasense has raised $34.5M.

  • Who are Medasense’s investors?

    Deloitte Launchpad, Sabadell Venture Capital, MedTech Innovator, Baxter Ventures, and OTV are 5 of 10 investors who have invested in Medasense.

  • Who are Medasense’s competitors?

    Dolosys, Biotricity, KARL STORZ, MDoloris Medical Systems, and Meril Life Sciences are competitors of Medasense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »